This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

DOJ seeks 4-month delay, again, in generic price-fixing class actions

By Leah Nylen ( February 8, 2019, 19:25 GMT | Insight) -- The US Department of Justice asked a Philadelphia federal judge to delay by another four months class actions accusing major pharmaceutical companies — including Mylan and Teva — of fixing prices on dozens of generic drugs. ​US District Judge Cynthia Rufe, who is overseeing the cases, said she will decide next week after viewing a confidential written report by prosecutors, but said she's “very concerned” by the continued need to stay the case, considering the length of the DOJ’s investigation.The US Department of Justice asked a Philadelphia federal judge to delay by another four months class actions accusing major pharmaceutical companies — including Mylan and Teva — of fixing prices on dozens of generic drugs....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections